Page last updated: 2024-08-21

lithocholic acid and Obesity

lithocholic acid has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19901 (25.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Deng, QF; Gao, LX; He, HB; Li, J; Li, JY; Ma, WP; Qiu, WW; Tang, CL; Tang, J; Yang, F1
Bian, Z; Ge, K; Han, X; Huang, F; Jia, W; Li, M; Qu, C; Rajani, C; Wang, S; Wei, M; Xie, G; Yang, W; Zhang, Y; Zhao, A; Zhao, L; Zheng, X1
Aa, J; Aa, N; Cao, B; Chen, Q; Fei, F; Feng, D; Feng, S; Ge, C; Guo, GL; Guo, J; He, J; Huang, J; Kong, B; Pan, Y; Schumacher, JD; Shen, J; Sun, R; Wang, G; Wang, P; Yang, CS; Yang, N; Yu, X1
Banwell, JG; Lockwood, DH; Nair, PP; Sherr, HP; White, JJ1

Other Studies

4 other study(ies) available for lithocholic acid and Obesity

ArticleYear
Synthesis and biological evaluation of 4,4-dimethyl lithocholic acid derivatives as novel inhibitors of protein tyrosine phosphatase 1B.
    Bioorganic & medicinal chemistry letters, 2012, Dec-01, Volume: 22, Issue:23

    Topics: Binding Sites; Catalytic Domain; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Kinetics; Lithocholic Acid; Molecular Docking Simulation; Obesity; Protein Tyrosine Phosphatase, Non-Receptor Type 1; Structure-Activity Relationship

2012
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility.
    EBioMedicine, 2020, Volume: 55

    Topics: Adipose Tissue, Brown; Animals; Body Mass Index; Chenodeoxycholic Acid; Cholestenones; Clostridiales; Cohort Studies; Diet, High-Fat; Disease Models, Animal; Disease Susceptibility; Gastrointestinal Microbiome; Gene Expression Regulation; Glucagon-Like Peptide 1; Humans; Ileum; Lithocholic Acid; Male; Metagenomics; Mice; Mice, Inbred C57BL; Obesity; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Uncoupling Protein 1; Ursodeoxycholic Acid

2020
Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Molecular pharmacology, 2017, Volume: 91, Issue:2

    Topics: Animals; Bacteria; Berberine; Bile Acids and Salts; Body Weight; CD36 Antigens; Diet, High-Fat; Feces; Gastrointestinal Microbiome; Gene Expression Regulation; Hypolipidemic Agents; Intestinal Mucosa; Lipid Metabolism; Lithocholic Acid; Liver; Male; Mice, Inbred C57BL; Obesity; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Taurocholic Acid; Triglycerides

2017
Bile acid metabolism and hepatic disease following small bowel bypass for obesity.
    The American journal of clinical nutrition, 1974, Volume: 27, Issue:12

    Topics: Adult; Bile; Bile Acids and Salts; Bilirubin; Chenodeoxycholic Acid; Cholic Acids; Deoxycholic Acid; Fatty Liver; Female; Glycine; Humans; Ileum; Jejunum; Lithocholic Acid; Liver; Liver Cirrhosis; Liver Diseases; Male; Obesity; Postoperative Complications; Protein Deficiency; Sulfuric Acids; Taurine

1974